UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 243.20
-0.70 (-0.29%)
Jul 22, 2026, 10:04 AM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €46.43 billion as of July 21, 2026. Its market cap has increased by 40.97% in one year.
Market Cap
46.43B
Enterprise Value
46.31B
Revenue
7.74B
Ranking
n/a
PE Ratio
30.37
Stock Price
€243.20
ChartMarket Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 46.43B, an increase of 5,112.86%. That is a compound annual growth rate of 13.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 46.43B | 2.42% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.05B |
| Financière de Tubize | 9.17B |
| Onward Medical | 171.04M |
| Hyloris Pharmaceuticals | 129.36M |
| European Medical Solutions | 17.52M |
| Celyad Oncology | 11.64M |
| BioSenic | 1.31M |
| Oxurion NV | 248.34K |